Status:
UNKNOWN
Intestinal Microbiota and Antimicrobial Resistance
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Drug Resistance, Microbial
Eligibility:
All Genders
18+ years
Brief Summary
Antimicrobial resistance is regarded as one of the major global public health threats, causing at least 700,000 deaths per year. It has been estimated that if the current problem of antimicrobial resi...
Eligibility Criteria
Inclusion
- Adults aged 18 years or above, and
- Radiological evidence of acute ischaemic or hemorrhagic stroke
- Within two days of hospital admission
Exclusion
- Use of antibiotics within 4 weeks prior to the time of screening
- Underlying gastrointestinal diseases, including gastrointestinal malignancy, inflammatory bowel disease, resection of small or large bowel
- Pregnancy
Key Trial Info
Start Date :
August 6 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03794453
Start Date
August 6 2018
End Date
December 31 2024
Last Update
August 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Shatin, Hong Kong